Fidson Healthcare Plc (NGX:FIDSON)

Market Cap	63.11B
Revenue (ttm)	100.32B
Net Income (ttm)	7.99B
Shares Out	2.29B
EPS (ttm)	3.49
PE Ratio	7.88
Forward PE	n/a
Dividend	1.00 (3.91%)
Ex-Dividend Date	Jul 14, 2025

Volume	3,817,533
Average Volume	914,867
Open	26.00
Previous Close	25.55
Day's Range	26.00 - 27.50
52-Week Range	12.40 - 25.55
Beta	0.32
RSI	91.42
Earnings Date	Apr 28, 2025

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered i...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 674
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: FIDSON

Financial Performance

In 2024, Fidson Healthcare's revenue was 84.19 billion, an increase of 58.70% compared to the previous year's 53.05 billion. Earnings were 5.78 billion, an increase of 60.20%.